Clinical Trial Update: Phase 2 Trial of Pertuzumab and Trastuzumab With Weekly Paclitaxel and Chemotherapy for HER2 Positive Breast Cancer [Phase 2]

View source ↗

Summary

Phase 2 trial evaluating pertuzumab and trastuzumab with weekly paclitaxel and chemotherapy for HER2-positive breast cancer has completed with results posted.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Breast Cancer

Drugs mentioned

• PACLITAXEL (PACLITAXEL)
• Pertuzumab (pertuzumab)
• Trastuzumab (trastuzumab)

Snippet

Sponsor: Yale University | Conditions: Her2-Positive Breast Cancer | Phase 2 | Status: COMPLETED | Results posted: 2020-03-31